MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/idr.s604463

Медицинская библиотека · Infection and drug resistance · 2026

Risk Stratification for ESBL-Producing Enterobacterales in Elderly Diabetic Patients with Urinary Tract Infections: A Multicenter Model to Support Empirical Antibiotic Decision-Making.

Huang Tingting, Qin Jibao, Jiang Xi, Hu Ming, Wang Jiaping, Chen Kaiyong, Yang Fumeng, Gu Jin, Wu Huiyi, Chen Xinkuan

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Antimicrobial resistance among elderly diabetic patients with urinary tract infections (UTIs) poses a significant challenge for empirical antibiotic therapy. Delayed availability of microbiological susceptibility results often leads to treatment mismatch and inappropriate broad-spectrum antibiotic use. This study aimed to develop and validate a clinically interpretable risk stratification model to estimate the probability of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales isolation prior to microbiological confirmation, thereby supporting early empirical antibiotic decision-making.

METHODS

We conducted a multicenter retrospective cohort study including elderly (≥60 years) patients with type 2 diabetes and positive urine cultures. Multivariable logistic regression was used to construct a prediction model for ESBL-positive isolation. Model discrimination and calibration were evaluated using the area under the receiver operating characteristic curve (AUC), Brier score, calibration plots, and bootstrap internal validation. Internal-external cross-validation and independent external validation were performed to assess model transportability. Decision curve analysis (DCA) was applied to evaluate clinical net benefit across threshold probabilities.

RESULTS

A total of 612 patients were included, of whom 364 (58.6%) had ESBL-positive isolates. Independent predictors included diabetes duration ≥10 years, HbA1c ≥8.5%, recent antibiotic exposure, urinary tract device use, and low-level pyuria (<5 WBC/HPF). The model demonstrated stable discrimination (AUC 0.81 in the training set; 0.79 in internal validation; 0.81 in external validation) and good calibration (Brier score 0.18-0.19). Decision curve analysis showed meaningful clinical net benefit across a wide range of threshold probabilities (10%-65%). Exploratory analysis indicated that empirical therapy mismatch was associated with prolonged hospitalization and increased sepsis incidence, underscoring the potential clinical relevance of early resistance risk identification.

CONCLUSION

This multicenter risk stratification model provides a practical tool for early estimation of ESBL-producing Enterobacterales risk in elderly diabetic patients with UTIs. By integrating routinely available clinical and laboratory variables, the model may support antimicrobial stewardship efforts and improve empirical antibiotic decision-making before susceptibility results become available. Prospective validation in diverse healthcare settings is warranted to confirm its clinical impact.

Для цитирования: Huang Tingting, Qin Jibao, Jiang Xi, Hu Ming, Wang Jiaping, Chen Kaiyong, Yang Fumeng, Gu Jin, Wu Huiyi, Chen Xinkuan. Risk Stratification for ESBL-Producing Enterobacterales in Elderly Diabetic Patients with Urinary Tract Infections: A Multicenter Model to Support Empirical Antibiotic Decision-Making.. Infection and drug resistance. 2026. DOI: 10.2147/idr.s604463.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.